Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days after their stroke than those receiving standard clot removal, according to preliminary late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2025.
ICU Medical to close Minnesota facility, cut 83 jobs
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: ICU Medical is preparing to
July 23, 2024